FTC, FDA to Halt Fraudulent Diabetes Cures, Treatments

FTC, FDA to Halt Fraudulent Diabetes Cures, Treatments
FTC and FDA, working with government agencies in Mexico and Canada, have launched an initiative to stop deceptive Internet advertisements and sales of products misrepresented as cures or treatments for diabetes. The ongoing joint campaign has so far included approximately 180 warning letters and other advisories sent to online outlets in the three countries. The FDA letters warn firms that failure to promptly correct the violations may result in enforcement action without further notice, which may include seizure of volatile products and/or injunctions against the manufacturers and distributors.